Analytics: USP129 Analytical procedures for recombinant therapeutic monoclonal antibodies

This 'Members Only' survey examines company approaches to USP129.  In total it covers the responses from 11 companies and also covers how they approach equivalence and deal with different products.

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.

Preview